BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lymphoma AND RB1, OSRC, ENSG00000139687, 5925, RB, P06400 AND Diagnosis
52 results:

  • 1. Adding a Gene Expression Profile Test to Aid Differential diagnosis and Treatment in Aggressive Large B-Cell lymphoma: An Early Exploratory Economic Evaluation.
    Bouttell J; Fraser H; Goodlad JR; Hopkins D; McKay P; Oien KA; Seligmann B; von Delft S; Hawkins N
    Appl Health Econ Health Policy; 2024 Mar; 22(2):243-254. PubMed ID: 38017318
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. [A Case of Malignant Rectal B Cell lymphoma That Was Difficult to Differentiate from Rectal Neuroendocrine Tumor].
    Murao S; Danno K; Nakamichi I; Takeda T; Fujino S; Takada N; Yamamoto K; Higashiguchi M; Noguchi K; Toyoda Y; Nakane S; Yamamoto H; Hirao T; Oka Y
    Gan To Kagaku Ryoho; 2022 Dec; 49(13):1793-1795. PubMed ID: 36733001
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Targeted Treatment and Immunotherapy in High-risk and Relapsed/ Refractory Pediatric Acute Lymphoblastic Leukemia.
    Graiqevci-Uka V; Behluli E; Spahiu L; Liehr T; Temaj G
    Curr Pediatr Rev; 2023; 19(2):150-156. PubMed ID: 36056858
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Genotyping of cerebrospinal fluid in lung cancer patients with leptomeningeal metastasis.
    Nie N; Zhou H; Zhang K; Liu L; Luo N; Wang R; Li X; Zhu M; Hu C; Wang Y; Liu Z; Li L; He Y
    Thorac Cancer; 2022 Sep; 13(18):2574-2583. PubMed ID: 35896160
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Decreased expression of T-cell-associated immune markers predicts poor prognosis in patients with follicular lymphoma.
    Rai S; Inoue H; Sakai K; Hanamoto H; Matsuda M; Maeda Y; Haeno T; Watatani Y; Kumode T; Serizawa K; Taniguchi Y; Hirase C; Espinoza JL; Morita Y; Tanaka H; Ashida T; Tatsumi Y; Nishio K; Matsumura I
    Cancer Sci; 2022 Feb; 113(2):660-673. PubMed ID: 34837284
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. [IgG-variant Bing-Neel syndrome diagnosed by detecting MYD88 L265P mutation in the cerebrospinal fluid cells].
    Maruyama Y; Nishikii H; Matsuoka R; Makishima K; Kurita N; Kusakabe M; Yokoyama Y; Kato T; Sakata-Yanagimoto M; Obara N; Nakamura N; Chiba S
    Rinsho Ketsueki; 2021; 62(10):1493-1498. PubMed ID: 34732622
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Low absolute lymphocyte count is a poor prognostic factor for untreated advanced follicular lymphoma treated with rituximab plus bendamustine: results of the prospective phase 2 CONVERT trial.
    Rai S; Inoue H; Hanamoto H; Matsuda M; Maeda Y; Wada Y; Haeno T; Watatani Y; Kumode T; Hirase C; Espinoza JL; Morita Y; Tanaka H; Tatsumi Y; Matsumura I
    Int J Hematol; 2021 Aug; 114(2):205-216. PubMed ID: 33864623
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Long-term follow-up after rituximab plus bendamustine in a patient with relapsed or refractory hairy cell leukemia variant: A case report.
    Imoto N; Koyama D; Sugiura I; Kurahashi S
    Medicine (Baltimore); 2021 Feb; 100(5):e24457. PubMed ID: 33592897
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Frequency and Correlation of Common Genes Copy Number Alterations in Childhood Acute Lymphoblastic Leukemia with Prognosis.
    Hosein Pour Feizi A; Zeinali S; Toporski J; Sheervalilou R; Mehranfar S
    Asian Pac J Cancer Prev; 2020 Dec; 21(12):3493-3500. PubMed ID: 33369444
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Surveilling Russell body
    Peruhova M; Peshevska-Sekulovska M; Georgieva V; Panayotova G; Dikov D
    World J Gastroenterol; 2020 Sep; 26(33):5050-5059. PubMed ID: 32952348
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. MLPA and DNA index improve the molecular diagnosis of childhood B-cell acute lymphoblastic leukemia.
    Yu CH; Lin TK; Jou ST; Lin CY; Lin KH; Lu MY; Chen SH; Cheng CN; Wu KH; Wang SC; Chang HH; Li MJ; Ni YL; Su YN; Lin DT; Chen HY; Harrison CJ; Hung CC; Lin SW; Yang YL
    Sci Rep; 2020 Jul; 10(1):11501. PubMed ID: 32661308
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Comprehensive chromosomal aberrations in a case of a patient with TCF3-HLF-positive BCP-ALL.
    Lejman M; Włodarczyk M; Zawitkowska J; Kowalczyk JR
    BMC Med Genomics; 2020 Apr; 13(1):58. PubMed ID: 32245383
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Chromosomal microarray analysis is superior in identifying cryptic aberrations in patients with acute lymphoblastic leukemia at diagnosis/relapse as a single assay.
    Chen C; Heng EYH; Lim AST; Lau LC; Lim TH; Wong GC; Tien SL
    Int J Lab Hematol; 2019 Aug; 41(4):561-571. PubMed ID: 31112375
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Genomic subtyping and therapeutic targeting of acute erythroleukemia.
    Iacobucci I; Wen J; Meggendorfer M; Choi JK; Shi L; Pounds SB; Carmichael CL; Masih KE; Morris SM; Lindsley RC; Janke LJ; Alexander TB; Song G; Qu C; Li Y; Payne-Turner D; Tomizawa D; Kiyokawa N; Valentine M; Valentine V; Basso G; Locatelli F; Enemark EJ; Kham SKY; Yeoh AEJ; Ma X; Zhou X; Sioson E; Rusch M; Ries RE; Stieglitz E; Hunger SP; Wei AH; To LB; Lewis ID; D'Andrea RJ; Kile BT; Brown AL; Scott HS; Hahn CN; Marlton P; Pei D; Cheng C; Loh ML; Ebert BL; Meshinchi S; Haferlach T; Mullighan CG
    Nat Genet; 2019 Apr; 51(4):694-704. PubMed ID: 30926971
    [TBL] [Abstract] [Full Text] [Related]  

  • 15.
    Martín-Garcia D; Navarro A; Valdés-Mas R; Clot G; Gutiérrez-Abril J; Prieto M; Ribera-Cortada I; Woroniecka R; Rymkiewicz G; Bens S; de Leval L; Rosenwald A; Ferry JA; Hsi ED; Fu K; Delabie J; Weisenburger D; de Jong D; Climent F; O'Connor SJ; Swerdlow SH; Torrents D; Beltran S; Espinet B; González-Farré B; Veloza L; Costa D; Matutes E; Siebert R; Ott G; Quintanilla-Martinez L; Jaffe ES; López-Otín C; Salaverria I; Puente XS; Campo E; Beà S
    Blood; 2019 Feb; 133(9):940-951. PubMed ID: 30538135
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Simultaneous detection of ABL1 mutation and IKZF1 deletion in Philadelphia chromosome-positive acute lymphoblastic leukemia using a customized target enrichment system panel.
    Aoe M; Ishida H; Matsubara T; Karakawa S; Kawaguchi H; Fujiwara K; Kanamitsu K; Washio K; Okada K; Shibakura M; Shimada A
    Int J Lab Hematol; 2018 Aug; 40(4):427-436. PubMed ID: 29575541
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Dual occurrence of ALK G1202R solvent front mutation and small cell lung cancer transformation as resistance mechanisms to second generation ALK inhibitors without prior exposure to crizotinib. Pitfall of solely relying on liquid re-biopsy?
    Ou SI; Lee TK; Young L; Fernandez-Rocha MY; Pavlick D; Schrock AB; Zhu VW; Milliken J; Ali SM; Gitlitz BJ
    Lung Cancer; 2017 Apr; 106():110-114. PubMed ID: 28285684
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. [Copy number alterations in adult patients with mature B acute lymphoblastic leukemia treated with specific immunochemotherapy].
    Ribera J; Zamora L; García O; Hernández-Rivas JM; Genescà E; Ribera JM
    Med Clin (Barc); 2016 Dec; 147(11):488-491. PubMed ID: 28126143
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Distinctive genotypes in infants with T-cell acute lymphoblastic leukaemia.
    Mansur MB; van Delft FW; Colman SM; Furness CL; Gibson J; Emerenciano M; Kempski H; Clappier E; Cave H; Soulier J; Pombo-de-Oliveira MS; Greaves M; Ford AM
    Br J Haematol; 2015 Nov; 171(4):574-84. PubMed ID: 26205622
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Novel gene targets detected by genomic profiling in a consecutive series of 126 adults with acute lymphoblastic leukemia.
    Safavi S; Hansson M; Karlsson K; Biloglav A; Johansson B; Paulsson K
    Haematologica; 2015 Jan; 100(1):55-61. PubMed ID: 25261097
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 3.